Murphy et al., 2006 - Google Patents
IL‐3, IL‐5, and GM‐CSF signaling: crystal structure of the human beta‐common receptorMurphy et al., 2006
- Document ID
- 16595136856377902461
- Author
- Murphy J
- Young I
- Publication year
- Publication venue
- Vitamins & Hormones
External Links
Snippet
The cytokines, interleukin‐3 (IL‐3), interleukin‐5 (IL‐5), and granulocyte‐macrophage colony stimulating factor (GM‐CSF), are polypeptide growth factors that exhibit overlapping activities in the regulation of hematopoietic cells. They appear to be primarily involved in …
- 108010002386 Interleukin-3 0 title abstract description 121
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/746—Erythropoetin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Murphy et al. | IL‐3, IL‐5, and GM‐CSF signaling: crystal structure of the human beta‐common receptor | |
| Broughton et al. | The GM–CSF/IL‐3/IL‐5 cytokine receptor family: from ligand recognition to initiation of signaling | |
| Grimley et al. | Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation | |
| Collins et al. | Identification of specific residues of human interleukin 2 that affect binding to the 70-kDa subunit (p70) of the interleukin 2 receptor. | |
| Livnah et al. | Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 Å | |
| Hudson et al. | Characterization of the receptor binding sites of human leukemia inhibitory factor and creation of antagonists | |
| Spangler et al. | Insights into cytokine–receptor interactions from cytokine engineering | |
| Jiang et al. | Structure of the active core of human stem cell factor and analysis of binding to its receptor kit | |
| Carr et al. | Structure of the complete extracellular domain of the common β subunit of the human GM-CSF, IL-3, and IL-5 receptors reveals a novel dimer configuration | |
| Broughton et al. | The βc receptor family–Structural insights and their functional implications | |
| Keegan et al. | An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth | |
| Bravo et al. | Crystal structure of a cytokine‐binding region of gp130 | |
| Verstraete et al. | Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases | |
| Hercus et al. | The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease | |
| Yin et al. | Strategies for targeting protein–protein interactions with synthetic agents | |
| Nickel et al. | The crystal structure of the BMP-2: BMPR-IA complex and the generation of BMP-2 antagonists | |
| Stroud et al. | Mechanistic diversity of cytokine receptor signaling across cell membranes | |
| Braden et al. | Anatomy of an antibody molecule: structure, kinetics, thermodynamics and mutational studies of the antilysozyme antibody D1. 3 | |
| Savvides et al. | Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots | |
| JP2001503266A (en) | Erythropoietin receptor agonists rearranged in a ring | |
| ZA200208795B (en) | Mammalian cytokine receptor subunit proteins, related reagents and methods. | |
| Reidhaar-Olson et al. | Identification of residues critical to the activity of human granulocyte colony-stimulating factor | |
| Olins et al. | Saturation Mutagenesis of Human Interleukin-3 (∗) | |
| de Moura et al. | Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22 | |
| US20090305962A1 (en) | IL-6 binding proteins |